Yiu, Z., Ashcroft, D., Evans, I., McElhone, K., Lunt, M., Smith, C., …Mason, K. (2019). Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology, 180(2), 329 - 337. https://doi.org/10.1111/bjd.17036